These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33071824)

  • 1. The Role of K
    Baculis BC; Zhang J; Chung HJ
    Front Physiol; 2020; 11():568667. PubMed ID: 33071824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heteromeric Assembly of Truncated Neuronal Kv7 Channels: Implications for Neurologic Disease and Pharmacotherapy.
    Li J; Maghera J; Lamothe SM; Marco EJ; Kurata HT
    Mol Pharmacol; 2020 Sep; 98(3):192-202. PubMed ID: 32580997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous Deletion of Epilepsy Gene
    Tracy GC; Wilton AR; Rhodes JS; Chung HJ
    Front Behav Neurosci; 2022; 16():930216. PubMed ID: 35928789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced axonal surface expression and phosphoinositide sensitivity in K
    Kim EC; Zhang J; Pang W; Wang S; Lee KY; Cavaretta JP; Walters J; Procko E; Tsai NP; Chung HJ
    Neurobiol Dis; 2018 Oct; 118():76-93. PubMed ID: 30008368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KCNQ/Kv7 channel activator flupirtine protects against acute stress-induced impairments of spatial memory retrieval and hippocampal LTP in rats.
    Li C; Huang P; Lu Q; Zhou M; Guo L; Xu X
    Neuroscience; 2014 Nov; 280():19-30. PubMed ID: 25234320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic potential of neuronal KCNQ channel modulators.
    Gribkoff VK
    Expert Opin Ther Targets; 2003 Dec; 7(6):737-48. PubMed ID: 14640909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural determinants of M-type KCNQ (Kv7) K+ channel assembly.
    Schwake M; Athanasiadu D; Beimgraben C; Blanz J; Beck C; Jentsch TJ; Saftig P; Friedrich T
    J Neurosci; 2006 Apr; 26(14):3757-66. PubMed ID: 16597729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kv7 Channels and Excitability Disorders.
    Jones F; Gamper N; Gao H
    Handb Exp Pharmacol; 2021; 267():185-230. PubMed ID: 33860384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of KV7/KCNQ potassium channel enhances neuronal differentiation of PC12 cells.
    Zhou N; Huang S; Li L; Huang D; Yan Y; Du X; Zhang H
    Neuroscience; 2016 Oct; 333():356-67. PubMed ID: 27450567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Kv7.2 in Neurodevelopment: Insights and Gaps in Our Understanding.
    Dirkx N; Miceli F; Taglialatela M; Weckhuysen S
    Front Physiol; 2020; 11():570588. PubMed ID: 33192566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous loss of epilepsy gene KCNQ2 alters social, repetitive and exploratory behaviors.
    Kim EC; Patel J; Zhang J; Soh H; Rhodes JS; Tzingounis AV; Chung HJ
    Genes Brain Behav; 2020 Jan; 19(1):e12599. PubMed ID: 31283873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release.
    Vervaeke K; Gu N; Agdestein C; Hu H; Storm JF
    J Physiol; 2006 Oct; 576(Pt 1):235-56. PubMed ID: 16840518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gain of function due to increased opening probability by two
    Nappi M; Barrese V; Carotenuto L; Lesca G; Labalme A; Ville D; Smol T; Rama M; Dieux-Coeslier A; Rivier-Ringenbach C; Soldovieri MV; Ambrosino P; Mosca I; Pusch M; Miceli F; Taglialatela M
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2116887119. PubMed ID: 35377796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the mechanism of action of the Kv7 channel opener, retigabine in the treatment of epilepsy.
    Zahra A; Liu R; Wang J; Wu J
    Neurol Sci; 2023 Nov; 44(11):3819-3825. PubMed ID: 37442907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tannic acid modulates excitability of sensory neurons and nociceptive behavior and the Ionic mechanism.
    Zhang X; Zhang H; Zhou N; Xu J; Si M; Jia Z; Du X; Zhang H
    Eur J Pharmacol; 2015 Oct; 764():633-642. PubMed ID: 26134502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity-dependent downregulation of M-Type (Kv7) K⁺ channels surface expression requires the activation of iGluRs/Ca²⁺/PKC signaling pathway in hippocampal neuron.
    Li C; Lu Q; Huang P; Fu T; Li C; Guo L; Xu X
    Neuropharmacology; 2015 Aug; 95():154-67. PubMed ID: 25796298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Targeting of Neuronal Kv7.2/3 Channels: A Focus on Chemotypes and Receptor Sites.
    Miceli F; Soldovieri MV; Ambrosino P; Manocchio L; Mosca I; Taglialatela M
    Curr Med Chem; 2018; 25(23):2637-2660. PubMed ID: 29022505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonreciprocal mechanisms in up- and downregulation of spinal motoneuron excitability by modulators of KCNQ/Kv7 channels.
    Lombardo J; Harrington MA
    J Neurophysiol; 2016 Nov; 116(5):2114-2124. PubMed ID: 27512022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs.
    Miceli F; Soldovieri MV; Martire M; Taglialatela M
    Curr Opin Pharmacol; 2008 Feb; 8(1):65-74. PubMed ID: 18061539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible link between KCNQ2- and STXBP1-related encephalopathies: STXBP1 reduces the inhibitory impact of syntaxin-1A on M current.
    Devaux J; Dhifallah S; De Maria M; Stuart-Lopez G; Becq H; Milh M; Molinari F; Aniksztejn L
    Epilepsia; 2017 Dec; 58(12):2073-2084. PubMed ID: 29067685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.